Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (301-310 of 397) with videos related to

Pageof 40
Sort By:
BMC Public Health|December 6, 2014
Relationship between exposure to the Avahan intervention and levels of reported condom use among men who have sex with men in southern IndiaKate M Mitchell, Anna M Foss, Banadakoppa M Ramesh, et al.
The Journal of Infectious Diseases|February 7, 2019
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?Janni Leung, Amy Peacock, Samantha Colledge, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 27, 2023
Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic reviewSandra Bivegete, Anna L McNaughton, Adam Trickey, et al.
The Lancet. Global Health|October 28, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic reviewSarah Larney, Amy Peacock, Janni Leung, et al.
The Lancet. Public Health|June 9, 2023
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011-20: a national retrospective cohort studyAndrew McAuley, Rosalyn Fraser, Megan Glancy, et al.
The Lancet. Global Health|December 17, 2019
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysisLindsey A Hines, Adam Trickey, Janni Leung, et al.
BMJ Open|February 1, 2019
Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysisJavier A Cepeda, Jose Luis Burgos, James G Kahn, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2019
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community careEithne Nic An Riogh, Davina Swan, Geoff McCombe, et al.
BMJ (Clinical Research Ed.)|February 28, 2020
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary careKirsty Roberts, John Macleod, Chris Metcalfe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
New HIV Infections Among Key Populations and Their Partners in 2010 and 2022, by World Region: A Multisources EstimationEline L Korenromp, Keith Sabin, John Stover, et al.
Pageof 40

Showing results (301-310 of 397) with videos related to

Sort By:
Pageof 40
BMC Public Health|December 6, 2014
Relationship between exposure to the Avahan intervention and levels of reported condom use among men who have sex with men in southern IndiaKate M Mitchell, Anna M Foss, Banadakoppa M Ramesh, et al.
The Journal of Infectious Diseases|February 7, 2019
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?Janni Leung, Amy Peacock, Samantha Colledge, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 27, 2023
Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic reviewSandra Bivegete, Anna L McNaughton, Adam Trickey, et al.
The Lancet. Global Health|October 28, 2017
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic reviewSarah Larney, Amy Peacock, Janni Leung, et al.
The Lancet. Public Health|June 9, 2023
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011-20: a national retrospective cohort studyAndrew McAuley, Rosalyn Fraser, Megan Glancy, et al.
The Lancet. Global Health|December 17, 2019
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysisLindsey A Hines, Adam Trickey, Janni Leung, et al.
BMJ Open|February 1, 2019
Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysisJavier A Cepeda, Jose Luis Burgos, James G Kahn, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2019
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community careEithne Nic An Riogh, Davina Swan, Geoff McCombe, et al.
BMJ (Clinical Research Ed.)|February 28, 2020
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary careKirsty Roberts, John Macleod, Chris Metcalfe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
New HIV Infections Among Key Populations and Their Partners in 2010 and 2022, by World Region: A Multisources EstimationEline L Korenromp, Keith Sabin, John Stover, et al.
Pageof 40